MRK — Merck & Co Cashflow Statement
0.000.00%
Last trade - 00:00
- $318.60bn
- $346.62bn
- $60.12bn
- 90
- 18
- 98
- 77
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9,777 | 4,523 | 12,358 | 14,526 | 377 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 2,634 | 7,411 | 2,189 | 5,010 | 12,861 |
Discontinued Operations | |||||
Extraordinary Items | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2,067 | -4,601 | -3,839 | -2,782 | -2,205 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 13,440 | 10,253 | 14,109 | 19,095 | 13,006 |
Capital Expenditures | -3,473 | -4,429 | -4,448 | -4,388 | -3,863 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 844 | -5,014 | -12,107 | -572 | -10,220 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,629 | -9,443 | -16,555 | -4,960 | -14,083 |
Financing Cash Flow Items | 5 | -436 | 8,210 | -240 | -328 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -8,861 | -2,832 | 2,593 | -9,119 | -4,810 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,967 | -1,769 | 14 | 4,606 | -5,864 |